image
Neurocrine Biosciences, Inc. NBIX
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
Watchlist
$ 117.44
-4.42 %
$ 11.9 B
Market Cap
31.32
P/E
CASH FLOW STATEMENT
390 M OPERATING CASH FLOW
14.88%
Growth Rates
1Year 14.88%
3Years 19.50%
5Years 30.92%
7Years 28.14%
10Years 31.25%
-467 M INVESTING CASH FLOW
-163.75%
Growth Rates
1Year -163.75%
3Years -386.19%
5Years -13.97%
7Years -26.34%
10Years -56.56%
65.3 M FINANCING CASH FLOW
127.87%
Growth Rates
1Year 127.87%
3Years 34.14%
5Years 17.20%
7Years 60.40%
10Years 28.54%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Neurocrine Biosciences, Inc.
image
Net Income 250 M
Depreciation & Amortization 21.3 M
Capital Expenditures -28.3 M
Stock-Based Compensation 194 M
Change in Working Capital 28.2 M
Others 900 K
Free Cash Flow 362 M

Cash Flow

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000 Dec-1999 Dec-1998 Dec-1997 Dec-1996
OPERATING CASH FLOW
Net Income 249.7 154.5 89.6 407.3 37.0 21.1 (142.5) (141.1) (88.9) (60.5) (46.1) 5.0 37.6 (8.0) (51.0) (88.6) (207.3) (107.2) (22.2) (45.8) (30.3) (94.5) (36.9) (28.8) (16.8) (20.0) 5.1 5.9
Depreciation & Amortization 21.3 15.6 10.9 8.6 7.5 4.0 2.4 1.5 1.0 0.8 0.7 0.7 0.7 1.4 3.2 7.6 9.4 10.6 10.1 7.1 3.7 3.1 2.7 2.2 2.1 1.7 1.3 1.0
Deferred Income Tax (56.7) 19.1 4.3 (310.7) 11.0 0.7 (0.3) 89 K 2.7 0.6 (0.3) 61 K (0.8) (3.5) 4.8 4.2 (10.1) (13.9) (0.5) (0.5) 44.9 (1.2) 0 0 0 0 0 0
Stock Based Compensation 194.3 173.1 134.2 100.0 75.3 58.1 42.5 28.5 28.4 10.4 6.8 5.5 2.9 3.1 5.5 8.0 10.0 14.4 0.5 0.5 1.7 1.2 0 0 0 0 0 0
Other Operating Activities (46.9) 44.5 0.8 61.2 21.1 19.2 12.4 (0.9) 10.1 14 K (2.8) (32.8) (36.5) 66.0 (2.4) 6.7 121.8 7.9 (22.0) (36.4) 81 K (1.4) 10.6 7.5 2.2 9.9 2.8 0.5
Change in Working Capital 28.2 (67.4) 16.7 (37.9) 0.2 (1.8) (8.8) 5.8 8.7 1.6 12.1 (13.7) (4.5) (9.2) (13.2) (12.1) 16.9 (11.0) 3.3 (24.9) 17.0 13.5 1.8 0.4 2.2 (2.3) 1.8 (0.7)
Cash From Operations 389.9 339.4 256.5 228.5 152.1 101.4 (94.3) (106.2) (38.0) (47.1) (29.6) (35.3) (0.7) 49.9 (53.1) (74.2) (59.3) (99.3) (30.8) (100.0) 37.1 (79.4) (21.9) (18.6) (10.3) (10.7) 11.0 6.7
INVESTING CASH FLOW
Capital Expenditures (28.3) (16.5) (23.4) (10.9) (14.7) (24.8) (6.9) (4.1) (1.9) (1.6) (0.5) (1.0) (0.8) (0.3) 35 K (1.3) (0.6) (3.1) (7.2) (53.1) (50.4) (5.3) (3.8) (2.4) (2.1) (3.8) (6.4) (1.6)
Other Items (438.8) (160.6) (106.8) 15.0 (196.3) (218.1) (243.9) 117.0 (193.9) (103.8) 5.9 (33.8) (2.8) (54.4) 12.1 45.8 21.5 123.4 16.6 71.6 (136.2) (40.7) (12.8) (73.2) (19.1) 8.5 (0.8) (47.0)
Cash From Investing Activities (467.1) (177.1) (130.2) 4.1 (211.1) (242.9) (250.9) 112.9 (195.8) (105.4) 5.3 (34.8) (3.5) (54.7) 12.1 44.4 20.8 120.3 9.4 18.5 (186.6) (46.0) (16.6) (75.7) (21.2) 4.7 (7.2) (48.6)
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Debt Repaid 0 (279.0) 100 K (186.9) 0 0 502.8 0 0 0 0 0 0 0 0 (1.5) 56.6 (5.8) (6.6) 29.7 14.4 2.2 1.8 0.8 0 1.5 100 K (0.7)
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 65.3 0 27.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0.1 0 15 K 0 0 100 K 0
Cash From Financing Activities 65.3 (234.3) 27.4 (157.8) 27.3 29.5 516.6 2.4 277.0 138.7 5.3 83.7 0.3 21.5 9.9 (1.5) 57.2 10.1 10.3 36.7 211.1 5.8 181.3 94.1 41.0 1.9 0.7 46.8
CHANGE IN CASH
Net Change In Cash (11.6) (73.3) 153.7 74.8 (31.7) (112.0) 171.4 9.1 43.2 (13.8) (19.0) 13.6 (3.9) 16.7 (31.1) (31.2) 18.7 31.0 (11.1) (44.8) 61.5 (119.6) 142.8 (0.2) 9.6 (4.1) 4.5 4.9
FREE CASH FLOW
Free Cash Flow 361.6 322.9 233.1 217.6 137.3 76.6 (101.3) (110.3) (39.9) (48.8) (30.2) (36.3) (1.4) 49.6 (53.1) (75.5) (60.0) (102.4) (38.0) (153.1) (13.3) (84.7) (25.7) (21.1) (12.4) (14.5) 4.6 5.1